Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $36,251 | 1,702 | 98.5% |
| Education | $368.26 | 15 | 1.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $190.38 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,561 | 154 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $3,373 | 138 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,838 | 162 | $0 (2024) |
| ABBVIE INC. | $2,567 | 145 | $0 (2024) |
| Novo Nordisk Inc | $2,496 | 112 | $0 (2024) |
| PFIZER INC. | $1,782 | 100 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,666 | 48 | $0 (2024) |
| Amgen Inc. | $1,594 | 73 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,535 | 64 | $0 (2024) |
| Lilly USA, LLC | $1,439 | 85 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,917 | 195 | ABBVIE INC. ($670.53) |
| 2023 | $4,062 | 236 | AbbVie Inc. ($514.60) |
| 2022 | $4,020 | 212 | ABBVIE INC. ($454.75) |
| 2021 | $5,198 | 224 | AstraZeneca Pharmaceuticals LP ($568.73) |
| 2020 | $3,203 | 157 | AstraZeneca Pharmaceuticals LP ($424.65) |
| 2019 | $5,463 | 229 | Janssen Pharmaceuticals, Inc ($779.72) |
| 2018 | $6,099 | 237 | Janssen Pharmaceuticals, Inc ($762.53) |
| 2017 | $4,847 | 229 | Janssen Pharmaceuticals, Inc ($783.12) |
All Payment Transactions
1,719 individual payment records from CMS Open Payments — Page 1 of 69
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: VACCINES | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: Biological | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.94 | General |
| Category: GI | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $39.28 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Neuroscience | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 512 | 803 | $168,975 | $55,644 |
| 2022 | 13 | 583 | 915 | $146,638 | $61,012 |
| 2021 | 15 | 607 | 944 | $147,140 | $63,538 |
| 2020 | 15 | 630 | 936 | $143,062 | $57,000 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 220 | $66,775 | $20,351 | 30.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 44 | 102 | $25,698 | $8,794 | 34.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 61 | 61 | $19,828 | $8,285 | 41.8% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 49 | 53 | $23,340 | $7,990 | 34.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 30 | $13,476 | $4,348 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 36 | $7,809 | $2,214 | 28.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 17 | 17 | $3,043 | $1,289 | 42.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 63 | 68 | $4,576 | $758.60 | 16.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 34 | 66 | $1,632 | $628.32 | 38.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $1,241 | $552.50 | 44.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 33 | 96 | $1,168 | $308.16 | 26.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 36 | 37 | $389.00 | $126.17 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 239 | $53,717 | $22,769 | 42.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 69 | 69 | $18,975 | $9,658 | 50.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 54 | 57 | $19,335 | $7,630 | 39.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 40 | 47 | $14,288 | $6,594 | 46.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 41 | 92 | $16,884 | $6,461 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 52 | $8,461 | $3,201 | 37.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 23 | 23 | $2,070 | $1,616 | 78.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 38 | 81 | $2,106 | $770.37 | 36.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $1,320 | $767.28 | 58.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 61 | 65 | $5,200 | $707.84 | 13.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 15 | 17 | $1,787 | $354.66 | 19.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 38 | 111 | $1,887 | $351.71 | 18.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 37 | 38 | $608.00 | $130.41 | 21.4% |
About Dr. John Wenceslao, MD
Dr. John Wenceslao, MD is a Internal Medicine healthcare provider based in Bloomfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740203868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Wenceslao, MD has received a total of $36,810 in payments from pharmaceutical and medical device companies, with $3,917 received in 2024. These payments were reported across 1,719 transactions from 83 companies. The most common payment nature is "Food and Beverage" ($36,251).
As a Medicare-enrolled provider, Wenceslao has provided services to 2,332 Medicare beneficiaries, totaling 3,598 services with total Medicare billing of $237,194. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bloomfield, CT
- Active Since 07/26/2006
- Last Updated 06/21/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1740203868
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,834
- FARXIGA (Drug) $1,605
- ENTRESTO (Drug) $1,516
- XARELTO (Drug) $1,514
- INVOKANA (Drug) $1,227
- Ozempic (Drug) $1,179
- ELIQUIS (Drug) $1,172
- VRAYLAR (Drug) $1,162
- BREZTRI (Drug) $891.21
- XIFAXAN (Drug) $838.95
- UBRELVY (Drug) $822.97
- JARDIANCE (Drug) $818.93
- TRULICITY (Drug) $658.45
- SPRAVATO (Drug) $597.59
- Repatha (Biological) $579.54
- LINZESS (Drug) $519.77
- SOLIQUA 100/33 (Biological) $470.73
- MYRBETRIQ (Drug) $424.14
- JANUVIA (Drug) $416.96
- Prolia (Biological) $413.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bloomfield
Bechara Barrak, Md, MD
Internal Medicine — Payments: $38,899
Dr. Pranay Bhatt, M.d, M.D
Internal Medicine — Payments: $19,760
Dr. Roy Kellerman, Md, MD
Internal Medicine — Payments: $17,119
Sheila Silverman, Md, MD
Internal Medicine — Payments: $10,559
John Kelly, Md, MD
Internal Medicine — Payments: $8,306
Edwin Fierer, Md, MD
Internal Medicine — Payments: $8,160